Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART-Reference-Cited by-同舟云学术

Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART

Published:2015-12-24 Issue:4 Volume:71 Page:1056-1062
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:J. Antimicrob. Chemother.

Author:

Lambert-Niclot S.,George E. C.,Pozniak A.,White E.,Schwimmer C.,Jessen H.,Johnson M.,Dunn D.,Perno C. F.,Clotet B.,Plettenberg A.,Blaxhult A.,Palmisano L.,Wittkop L.,Calvez V.,Marcelin A. G.,Raffi F.

Funder

The French National Institute for Health and Medical Research—France Recherche Nord&Sud Sida-HIV Hépatites

the Instituto Superiore di Sanità—Rome, by the EU under the Sixth Framework programme

Gilead Sciences, Janssen Pharmaceuticals and Merck Laboratories

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/71/4/1056/6992834/dkv427.pdf

Reference28 articles.

1. European AIDS Clinical Society. European AIDS Clinical Society Guidelines for the Treatment of HIV-infected Adults . European AIDS Clinical Society (EACS). http://www.eacsociety.org/files/guidelines-7.1-english.pdf .

2. Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients

3. Effect of cumulating exposure to abacavir on the risk of cardiovascular disease events in patients from the Swiss HIV Cohort Study;Young;J Acquir Immune Defic Syndr,2015

4. Association of tenofovir exposure with kidney disease risk in HIV infection

5. Role of Traditional Risk Factors and Antiretroviral Drugs in the Incidence of Chronic Kidney Disease, ANRS CO3 Aquitaine Cohort, France, 2004–2012

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Two-drug antiretroviral regimens for HIV;BMJ;2023-09-01

2. Influence of UGT1A1 and SLC22A6 polymorphisms on the population pharmacokinetics and pharmacodynamics of raltegravir in HIV-infected adults: a NEAT001/ANRS143 sub-study;The Pharmacogenomics Journal;2022-10-20

3. Two-Drug Regimens for HIV—Current Evidence, Research Gaps and Future Challenges;Microorganisms;2022-02-14

4. Management of Comorbidities in Treated HIV Infection: A Long Way to Go;International Journal of Antimicrobial Agents;2022-01

5. Dual therapy with dolutegravir plus boosted protease inhibitor as maintenance or salvage therapy in highly experienced people living with HIV;International Journal of Antimicrobial Agents;2021-09